LCIF immagina un futuro in cui nessuna persona al mondo debba soffrire a causa dell'ipovisione prevenibile. Al fine di raggiungere questo obiettivo, le nostre iniziative per la vista vengono sviluppate e riviste continuamente da esperti, partner chiave, leader e staff di LCIF. Tutti i nostri programmi di sussidi per la vista si basano su una comprensione profonda delle problematiche della vista che vogliono alleviare e hanno obiettivi e fini chiari che vengono aggiornati quando cambiano le necessità. È solo attraverso strategie conosciute, ben formate e pianificate attentamente che possiamo vincere la nostra lotta contro le più devastanti malattie degli occhi che affliggono milioni di persone.

Lions can lead the fight by developing projects and applying for SightFirst grants focused on these 10 key areas:

• Cataract—the world’s leading cause of visual impairment.
• Childhood Blindness—an estimated 1.4 million children worldwide are blind.
• Diabetic Retinopathy—nearly half of the 220 million people with diabetes will develop some degree of vision loss during their lifetime.
• Education and Rehabilitation—just one out of 10 of the world’s people who are blind have access to education or rehabilitation services.
• Eye Health Education—quality education is needed to help millions of people who do not realize they have a condition that needs treatment or do not know how to seek treatment.
• Low Vision—nearly 246 million people in the world have low vision, and services are accessed by just 5 to 10 percent.
• Research—high quality research has the potential to improve our programs and benefit blindness prevention efforts worldwide.
• River Blindness—close to 37 million people are infected with river blindness, with another 100 million people in Africa and Latin America at risk for the disease.
• Trachoma—a disease that is the leading cause of preventable blindness worldwide and has caused irreversible blindness in approximately 8 million people.
• Uncorrected Refractive Error—easily correctable disorders are responsible for 43 percent of global vision impairment, with half of all cases going undetected and untreated.